XML 21 R4.htm IDEA: XBRL DOCUMENT v3.20.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Aug. 31, 2020
Aug. 31, 2019
Aug. 31, 2018
Revenue      
Revenue $ 261,162 $ 281,351 $ 284,188
Costs and Expenses      
Cost of products and services sold 161,615 180,163 175,136
Selling, general and administrative expenses 49,364 48,707 47,703
Research and product development costs 4,007 4,021 3,940
Operations optimization costs (Note 20) 807 986 1,272
Acquisition-related costs (Note 14) 274   393
Gain on sale of real estate (Note 19) (2,551)    
Write-down of certain assets under construction (Note 20) 405    
Loss on impairment of goodwill (Note 4)   2,410  
Operating income 47,241 45,064 55,744
Interest expense (246) (519) (1,172)
Gain on sale of license (Note 15)     1,085
Gain on sale of businesses (Note 18)     1,480
Other income (expense) (1,675) (992) (172)
Income before income taxes 45,320 43,553 56,965
Income taxes (Note 7) 11,163 10,842 13,822
Net income $ 34,157 $ 32,711 $ 43,143
Net income available to common shareholders, per common and common equivalent share (Note 17)      
Basic $ 3.62 $ 3.48 $ 4.60
Diluted $ 3.59 $ 3.46 $ 4.56
Weighted average shares outstanding      
Basic 9,359,940 9,334,232 9,296,648
Diluted 9,439,750 9,379,207 9,366,071
Cash dividends paid per share (in dollars per share) $ 0.80 $ 0.80 $ 0.80
Annual cash dividends declared per share $ 0.80 $ 0.80 $ 0.80
Product      
Revenue      
Revenue $ 257,742 $ 276,839 $ 278,962
Royalties and commissions      
Revenue      
Revenue $ 3,420 $ 4,512 $ 5,226